Advertisements

Fleet Enema Paed

Quick links to important sections

Fleet Enema Paed

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Fleet Enema Paed

Quick Facts: Fleet Enema Paed

Property Description
Active Ingredients Monosodium Phosphate and Disodium Phosphate
Form Ready-to-use Rectal Solution (Enema)
Pharmacological Class Saline Laxative / Osmotic Laxative
Common Use Relief of occasional constipation
Origin Synthetic (Inorganic salt combination)
Target Audience Paediatric (Children aged 2 to 11)

What Type of Medicine is Fleet Enema Paed?

Fleet Enema Paed is an over-the-counter (OTC) medicine supplied as a sterile, ready-to-use rectal solution specifically categorized as a Saline Laxative. It is designed as a Paediatric Enema, distinguished by its reduced volume and concentration tailored for children, typically aged 2 to 11.

This preparation is classified within the osmotic class of laxatives and is clinically recognized for its quick and reliable action in promoting bowel evacuation. Unlike oral medicines, the enema form ensures the active ingredients are delivered locally to the lower large intestine, making it a preferred option when prompt relief is required.

Composition and the Saline Laxative Mechanism

The active ingredients in Fleet Enema Paed are the inorganic salts Monosodium Phosphate and Disodium Phosphate, a combination commonly cited as Sodium Phosphate Monobasic and Dibasic. These synthetic salts define the product's function as a saline laxative.

These phosphate salts create an osmotic effect, which is the fundamental mechanism of this class of laxative. They draw water from the surrounding tissues into the colon. This influx of fluid serves to hydrate and soften the hard stool mass and increase the volume in the bowel. The resulting volume increase stimulates the natural muscle contractions (peristalsis) in the colon, leading to a fast-acting and predictable evacuation for the relief of occasional constipation.

Regulatory References

  1. MedlinePlus Drug Information
Advertisements

What side effects are possible with Fleet Enema Paed?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and essential safety constraints for sodium phosphate rectal solution, as documented in official government regulatory information.

Documented Adverse Reactions

Side effects are categorized by frequency and the body system affected (System-Organ Class or SOC):

Classification Examples of Reactions
Common Abdominal discomfort, bloating, rectal pain or irritation.
Frequency Not Known Hypersensitivity reactions (e.g., rash, hives), nausea, vomiting, acute kidney injury.

Serious and Clinically Significant Adverse Reactions

The most serious documented risk involves the potential for severe electrolyte disturbances, including life-threatening Hyperphosphatemia and Hypocalcemia. These imbalances can lead to complications such as cardiac arrhythmias (irregular heart rhythm) and, in extreme cases, cardiac arrest.

Safety Constraints and Risk Populations

Official regulatory documents emphasize strict limitations on use:

  • Pediatric Use: The product is contraindicated in children younger than 2 years of age. Young children are at a significantly higher risk of severe dehydration and electrolyte abnormalities.
  • Dose Limit: Do not use more than one dose in 24 hours. Serious adverse events are strongly associated with exceeding this limit.
  • Contraindicated Conditions: The product must not be used in individuals with pre-existing conditions that increase risk, including severe kidney impairment, heart failure, known or suspected bowel obstruction, and existing electrolyte imbalances.

Safety Profile Summary

This profile is structured to inform that while local effects are common, the primary concern lies in the rare, but potentially fatal, systemic risk of severe electrolyte imbalance. Strict adherence to the dosing limit and avoidance in contraindicated populations are mandatory safety requirements.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose of sodium phosphate enemas is defined in official regulatory documents as administering more than one dose within a 24-hour period or from prolonged retention of the solution. This exposure is associated with a severe risk of systemic toxicity.

Documented Overdose Manifestations and Outcomes

The primary manifestations stem from critical disturbances in fluid and electrolyte balance. Officially documented physiological findings include profound Hyperphosphatemia, Hypocalcemia, Hypernatremia, and resultant Severe Dehydration. These imbalances can escalate rapidly to life-threatening outcomes, including Acute Kidney Injury and severe Cardiac Arrhythmias. Specific manifestations reported in children include Tetany and Decreased Consciousness. The most severe outcomes, including Death, are documented in regulatory reports.

Population-Specific Overdose Notes: Official labeling confirms that children are more sensitive to the toxic effects of the product. Increased risk of severe outcomes is also noted for the elderly and in patients with pre-existing conditions such as kidney disease or cardiac disorders.

Emergency Action Requirements

Regulatory authorities mandate that patients Seek immediate medical attention or Get medical help right away if a suspected overdose has occurred. Urgent medical assessment is also required if severe adverse signs, such as rectal bleeding, are observed. Overdose management is symptomatic and supportive, prioritizing the immediate correction of the documented electrolyte imbalance and fluid deficit.

Advertisements

Therapeutic Uses of Fleet Enema Paed

What Fleet Enema Paed Treats: Main Uses and Benefits

Fleet Enema Paed is commonly used to help manage symptoms associated with acute or episodic manifestations in lower bowel function in children. Its therapeutic application is relevant across domains where short-term symptomatic assistance is needed.

The medicine may be part of symptomatic management for conditions like occasional constipation, fecal impaction, and for pre-procedural bowel cleansing. It assists with managing symptom clusters that create noticeable physiological strain, such as symptoms related to difficult defecation and physical discomfort stemming from retained stool.

This targeted support provides supportive relief that helps ease the child's distress, contributing to easing the overall symptom load during symptomatic phases. The supportive therapy is relevant for easing the overall symptom burden associated with acute lower bowel retention.

Fact Box: Symptomatic Focus
Symptom Category Acute gastrointestinal discomfort
Targeted Symptom Hard, dry, and retained stools
Key Benefit Contributes to improved comfort during symptomatic periods

Regulatory References

  1. DailyMed NLM label for Fleet Enema Child
Advertisements

Eligibility and Restrictions for Use

Fleet Enema Paed, a sodium phosphate saline laxative, is specifically formulated for use in children between the ages of 2 and 11 years to relieve occasional constipation. It should be used only as directed and is contraindicated in children under 2 years of age due to the risk of serious complications, including severe electrolyte imbalance and dehydration.


Contraindications

The product must not be used in patients, regardless of age, with certain pre-existing conditions, as it may cause harm or worsen the condition. Consult a healthcare professional immediately if any of these apply:

Condition Category Specific Contraindications
Gastrointestinal Known or suspected intestinal obstruction, Hirschsprung’s disease, anorectal malformation (imperforate anus), active inflammatory bowel disease, or acute abdominal pain, nausea, or vomiting.
Systemic/Metabolic Clinically significant kidney impairment, severe dehydration, congestive heart failure, pre-existing electrolyte disturbances, or hypersensitivity to the active ingredients.

It is also advised that the product not be used if the patient is taking other laxatives containing sodium phosphate or is on a sodium-restricted diet without medical supervision.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for the active ingredients (Monosodium Phosphate and Disodium Phosphate) based on governmental regulatory sources.

Pharmacodynamic and Physiological Interactions

Co-administration with other medicines that affect renal function or fluid balance increases the documented risk of severe electrolyte disturbances (specifically hyperphosphatemia) and dehydration. The medicinal product categories identified in regulatory documents with this potential interaction include:

  • Diuretics
  • ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
  • ARBs (Angiotensin Receptor Blockers)
  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

The combination with other sodium phosphate-containing laxatives (oral or rectal) is a formally contraindicated combination to prevent an excessive phosphate load and associated cardiac and renal harm.

Exposure and Timing Constraints

The purgative action may cause a physiological interaction by accelerating gastrointestinal transit, which can reduce the absorption and subsequent systemic exposure of concurrently administered oral medications.

Co-administration with Lithium may lead to a fall in its serum levels. This exposure reduction is a consequence of the sodium phosphate potentially causing hypernatremia, which can increase the clearance of Lithium.

Population and Dietary Notes

The regulatory labels identify the pediatric population (ages 2 to 11) as a specific population where the risks related to these electrolyte and dehydration interactions are a particular concern. Caution is also noted for use in children who are on a sodium-restricted diet, due to the sodium content of the preparation. The interaction profile is defined by these physiological constraints rather than metabolic or transporter-based mechanisms.

Advertisements

Mechanism of Action

How Fleet Enema Paed Works

Osmotic Fluid Dynamics and Colonic Water Shift

The mechanism is initiated by the osmotic properties of the active ingredients, Monosodium Phosphate and Disodium Phosphate, which establish a localized chain of physiological events. The creation of a high-solute, hypertonic environment within the rectal and sigmoid colon lumen establishes an osmotic gradient across the mucosal wall. This drives the rapid, passive movement of free water from the surrounding tissues into the colon. This influx achieves increased fecal hydration and an acute increase in the lumenal volume, which is critical for the next stage of the mechanism.


Reflex Neuromuscular Activation

The sudden volume expansion acts as a potent mechanical stimulus, activating stretch receptors (mechanoreceptors) embedded in the rectal wall. This stimulus initiates the robust Defecation Reflex, transmitted through both the local Myenteric Plexus and the extrinsic parasympathetic pathways. The reflex causes the simultaneous coordination of two opposing muscle groups: an increase in propulsive peristaltic contractions of the smooth muscle in the lower colon, and the reflex-mediated relaxation of the internal anal sphincter. This synchronized neuro-muscular event is the functional outcome of the reflex pathway.


Mechanistic Specificity and Synergy

The combination of the two phosphate salts ensures that the requisite osmotic load is achieved, while simultaneously providing a buffer system to maintain a functional pH environment, which supports the osmotic process. This physicochemical synergy, coupled with the direct peripheral delivery to the target site, allows the sequence—from water draw to reflex-driven movement—to proceed, describing the functional characteristics of this method of action.

Advertisements

Dosage and Administration Information

How to Use Fleet Enema Paed

This section describes the administration protocol for Fleet Enema Paed, detailing the approved route, age-specific volumes, and usage constraints.


Administration Scope

Instruction Detail
Route of administration The medicine is strictly for Rectal administration; it is not intended for oral consumption.
Dosing schedule Children 5 to 11 years: One bottle (approx. 59 mL delivered dose). Children 2 to under 5 years: One-half bottle (approx. 30 mL delivered dose).
Preparation requirements For the 2 to under 5 age group, the user must first remove 2 tablespoons of liquid (approx. 30 mL) from the bottle to ensure the correct dose volume.
Age-group rules The product is explicitly DO NOT USE in children under 2 years of age. Adult-size enemas are not to be given to children under 12 years.
Special procedural conditions The solution should be retained for a short time, typically 1 to 5 minutes, until a strong urge to evacuate is felt. Forcing the enema tip is prohibited.

Instruction Classifications

Classification Detail
Administration method type Local (Rectal)
Frequency pattern As-needed and Single Daily Dosage constrained (Not more than one administration in 24 hours)
Use-context constraints The product is designated for short-term use only, with labeling advising against use for more than 3 days without medical guidance.

The instructions define the protocol as a single, rectally administered dose delivered at an age-specific volume. This necessitates a preliminary preparation step for the younger pediatric group to ensure the precise dosage is administered. The protocol further restricts use to a single dose per 24 hours and mandates a short, maximum duration of use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fleet Enema Paed

This section outlines what the official research and scientific literature have studied regarding the paediatric sodium phosphate rectal solution, focusing on the types of evidence available and what remains uncertain, without providing any medical advice or instruction.


Research Evidence for Acute Occasional Constipation

Research has explored the use of this solution for research exploring occasional constipation symptoms in children. Studies conducted during periods of increased symptom activity include short-term randomized controlled trials (RCTs) that used the solution as a reference or compared it to other forms of enemas or to oral osmotic laxatives. The primary outcomes related to outcomes describing episodic or acute changes and monitored the time interval until a bowel movement occurred.

In these research scenarios, studies monitored the Time to Bowel Movement/Defecation, typically measured in minutes or within the initial hour. Studies reported patterns observed related to the measured changes in physical discomfort following the evacuation of retained stool. The evidence contributes to the broader evidence landscape but does not fully establish long-term effects or subsequent patterns of constipation after the single, acute use.


Research Evidence for Fecal Impaction and Disimpaction

The solution was evaluated in a research context involving more significant retained stool, known as fecal impaction or rectal fecal impaction (RFI). Studies exploring short-term symptom changes for this use often take the form of systematic reviews and meta-analyses of clinical trials, which used different treatments as references, including high-dose oral laxatives used for disimpaction. These studies focus on outcomes capturing phases of heightened symptom activity.

The research examined the rate of successful fecal disimpaction and the required number of days of treatment to clear the impaction. Findings from systematic reviews indicate that the outcomes measured during the study period for the acute disimpaction success rate showed patterns related to those observed with some oral treatments. However, the data show patterns related to varied definitions of treatment success across different studies.


Evidence Consistency and Uncertainty

Research highlights what is known and what is still uncertain about the evidence for this type of acute management. Overall, the evidence consistency varies across studies, particularly in trials that used different types of laxatives or enemas as references. While studies exploring short-term symptom changes generally indicate patterns of rapid clearance, data for certain groups remain insufficient.

Findings were mixed regarding long-term recurrence rates following disimpaction treatment. The certainty remains low for long-term effects, reflecting its study as an acute intervention. This means research focuses on immediate outcomes, and the results apply only to the populations studied under those specific, short-term research conditions.

Key Studies & References

  1. FDA DailyMed Label: Fleet Enema Child (Sodium Phosphate)
  2. MedlinePlus Drug Information: Sodium Phosphate Rectal
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fleet Enema Paed (FAQ)


Q: What is considered a non-effective response after using the enema?

Official product information defines a non-effective response as having no bowel movement or no liquid coming out of the rectum within 30 minutes after administration. The label states that if this occurs, use should be stopped and a healthcare provider should be contacted promptly.


Q: Can using Fleet Enema Paed too often cause a child to become dependent on laxatives?

According to official guidance, this product is intended only for short-term use, typically not more than three days. Using any laxative too often or for extended periods may cause the bowel to become overly reliant on the product, which is often referred to as laxative dependency.


Q: What should parents expect regarding the consistency of the stool after the enema works?

The product works by drawing water into the lower intestine, leading to a rapid and complete bowel movement. Because of this mechanism, the resulting stool is often liquid or watery. Official warnings state that use should be stopped if persistent diarrhea occurs.


Q: What types of allergic reactions are officially described for this medication?

Official safety documents list hypersensitivity reactions as documented adverse events. These types of reactions may include visible signs like a rash or hives, or more severe signs such as swelling of the face, lips, tongue, or throat.


Q: Is it necessary to increase the child's fluid intake when using a saline enema?

Yes, regulatory product information states that additional liquids by mouth are recommended when using this saline laxative. This measure supports overall hydration.


Q: Are there known interactions with common non-prescription pain relievers?

Regulatory documents caution that the use of this enema with certain medication classes, including Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), requires careful attention. NSAIDs, which include some common non-prescription pain relievers, can affect kidney function and increase the risk of severe electrolyte disturbances when combined with this product.


Q: Is it safe to use Fleet Enema Paed if a child is already taking a daily oral laxative like PEG 3350 (Miralax)?

The official product label includes a warning regarding the use of other laxatives. The label advises contacting a healthcare provider before using this enema if the child is currently taking any other laxative product or has already been using a laxative for a week or longer.


Q: Have there been studies on the long-term effects of using a phosphate enema periodically?

Official constraints define this product as an acute, short-term treatment, and the maximum duration of use is constrained to three days. The safety profile for repeated or periodic use over a long period has not been established in official regulatory documents, reflecting its study as an acute intervention.


Q: How long after the enema is given should a child be monitored for the first bowel movement?

The product is designed to produce a bowel movement quickly, typically within 1 to 5 minutes. The official warning states that if there is no bowel movement or no liquid comes out after 30 minutes, the product should not be used further, and a healthcare professional should be contacted.


Q: Are there alternatives to Fleet Enema Paed mentioned in official literature for similar issues?

While this product is for acute relief, general health monographs on constipation treatment often recommend first trying milder products. These alternatives may include stool softeners or bulk-forming laxatives, used as part of a comprehensive management strategy.


Q: Why is the drug described as working by increasing fluid in the intestine?

The active ingredients create an osmotic effect—a natural process that draws water from the body's surrounding tissues into the lower large intestine. This influx of fluid serves to hydrate the hard stool and rapidly increase the volume in the bowel, which naturally stimulates a bowel movement.


Q: Is Fleet Enema Paed the same product as the Pedia-Lax brand enema for children?

Official product labeling indicates that Fleet Enema Paed and the Pedia-Lax brand enema for children contain the same active ingredients: monobasic and dibasic sodium phosphate. Both are formulated as saline laxatives with the same volume and dosage guidelines for children aged 2 to 11.


Q: Is it true that this type of enema can only clear the lower part of the colon?

Yes, the enema is designed to work locally. Official product information states that the enema is formulated to induce the complete emptying of the left colon, which is the lower section of the large intestine, within a few minutes of administration.


Q: What are the inactive ingredients included in the Fleet Enema Paed solution?

The inactive ingredients listed in the official DailyMed label for the solution are benzalkonium chloride, disodium EDTA, and purified water.


Q: Is the applicator tip of the Fleet Enema Paed bottle guaranteed to be latex-free?

Yes, according to information on the product packaging, the enema devices are manufactured without the use of natural rubber latex.


Q: What should be done if the child feels dizzy after the enema is given?

Dizziness is listed in the warning section as a symptom that may indicate dehydration, which can be serious. The label states that if the child experiences dizziness, use should be stopped and prompt medical attention should be sought.


Q: Do official sources describe interactions with vitamin or herbal supplements?

Health monographs contain a general recommendation that all products being used—including any vitamins, non-prescription drugs, and herbal products—should be disclosed before use. This is noted because these substances may potentially affect the safety or effectiveness of the saline laxative.


Q: Is there a risk if a small amount of the enema solution is accidentally swallowed?

Yes, this product is strictly for rectal administration and may be harmful if swallowed. The label includes a prominent warning to immediately contact a Poison Control Center or seek emergency medical help if any accidental ingestion occurs.


Q: Is it safe to use this product if the child has an existing issue like hemorrhoids or an anal fissure?

Official warnings caution against forcing the applicator tip into the rectum, noting that injury can occur, especially if the patient has pre-existing hemorrhoids. Rectal pain or irritation is also a documented adverse reaction associated with use.


Q: Can the enema be used to cleanse a child's bowels for a specific medical procedure like an X-ray?

Yes, official indications for use include not only the relief of occasional constipation but also serving as part of a bowel cleansing regimen. This regimen can be used to prepare the colon for certain procedures, such as surgery, X-ray, or an endoscopic examination.


Q: Does using the product commonly cause flatulence or increased gas in children?

Mild abdominal discomfort, cramps, or gas and bloating are listed as possible adverse effects associated with the use of the product.


Q: Is there a best position for the child to be in to maximize the enema's effectiveness?

The official administration directions describe two positions suggested for use. These two methods are the left-side position (lying on the left side with one knee bent) and the knee-chest position.


Q: What is the core difference between Fleet Enema Paed and a glycerin suppository?

The key difference lies in the mechanism of action and site of activity. The saline enema works by drawing significant fluid into the left colon to induce a full emptying. In contrast, glycerin suppositories primarily work lower in the rectum to gently irritate the local lining and soften stool mass.

Advertisements

How should Fleet Enema Paed be stored and disposed of?

How to Store and Dispose of Fleet Enema Paed?

The storage and disposal of Fleet Enema Paed are governed by specific regulatory requirements to ensure product stability and safety. The enema must be stored at Room Temperature, generally defined as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C. It is mandatory to protect the product from freezing.

Handling and Child Safety

Store the product in its original container and note that it is designed for single administration only; reuse is prohibited. The medicine must be kept out of the reach of children to prevent accidental exposure.

Disposal Instructions

Dispose of any unused or expired product properly according to local requirements for pharmaceutical waste. Unless specifically advised by a regulatory authority, do not flush the medicine down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fleet Enema Paed found in:

A-Z Index: